Vitreoretinopathy, Proliferative
"Vitreoretinopathy, Proliferative" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vitreoretinal membrane shrinkage or contraction secondary to the proliferation of primarily retinal pigment epithelial cells and glial cells, particularly fibrous astrocytes, followed by membrane formation. The formation of fibrillar collagen and cellular proliferation appear to be the basis for the contractile properties of the epiretinal and vitreous membranes.
Descriptor ID |
D018630
|
MeSH Number(s) |
C11.768.890
|
Concept/Terms |
Vitreoretinopathy, Proliferative- Vitreoretinopathy, Proliferative
- Proliferative Vitreoretinopathies
- Vitreoretinopathies, Proliferative
- Vitreoretinopathy Neovascular Inflammatory
- Inflammatories, Vitreoretinopathy Neovascular
- Inflammatory, Vitreoretinopathy Neovascular
- Neovascular Inflammatories, Vitreoretinopathy
- Neovascular Inflammatory, Vitreoretinopathy
- Vitreoretinopathy Neovascular Inflammatories
- Proliferative Vitreoretinopathy
|
Below are MeSH descriptors whose meaning is more general than "Vitreoretinopathy, Proliferative".
Below are MeSH descriptors whose meaning is more specific than "Vitreoretinopathy, Proliferative".
This graph shows the total number of publications written about "Vitreoretinopathy, Proliferative" by people in this website by year, and whether "Vitreoretinopathy, Proliferative" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 1 | 0 | 1 |
2006 | 0 | 1 | 1 |
2009 | 0 | 1 | 1 |
2014 | 1 | 0 | 1 |
2022 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Vitreoretinopathy, Proliferative" by people in Profiles.
-
Pars Plana Vitrectomy with and without Supplemental Scleral Buckle for the Repair of Rhegmatogenous Retinal Detachment: A Meta-analysis. Ophthalmol Retina. 2022 10; 6(10):871-885.
-
Outcomes of Eyes Undergoing Multiple Surgical Interventions after Failure of Primary Rhegmatogenous Retinal Detachment Repair. Ophthalmol Retina. 2022 05; 6(5):339-346.
-
Ocriplasmin and its role in the management of vitreoretinal interface disorders. Int Ophthalmol Clin. 2014; 54(2):29-38.
-
Recessive mutations in TSPAN12 cause retinal dysplasia and severe familial exudative vitreoretinopathy (FEVR). Invest Ophthalmol Vis Sci. 2012 May 14; 53(6):2873-9.
-
MAP kinase pathway is involved in IGF-1-stimulated proliferation of human retinal pigment epithelial cells (hRPE). Curr Eye Res. 2009 Oct; 34(10):867-76.
-
Is autologous serum a tonic for the ailing corneal epithelium? Am J Ophthalmol. 2006 Aug; 142(2):316-7.
-
An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy. Arch Ophthalmol. 1998 Jan; 116(1):69-77.